1 - 5 of 5 Results Clear All
A research collaboration to target the protein tau with small molecules
Business Development News Release Neurological Disease Mucke Lab
Senior Investigator Katerina Akassoglou has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific community to reassess the complex relationship between the brain, immune, and vascular systems.
Business Development Institutional News Assay Development and Drug Discovery Core Multiple Sclerosis Neurological Disease Akassoglou Lab
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
Corporate Ventures and Translation Business Development News Release Epilepsy Neurological Disease Palop Lab
Study will use innovative technology to focus on neurodegenerative diseases
Business Development News Release Finkbeiner Lab
SAN FRANCISCO and PRINCETON, NJ—December 22, 2011—Bristol-Myers Squibb Company (NYSE:BMY) and the Gladstone Institutestoday announced the formation of a discovery-based research collaboration to identify and validate novel targets in Alzheimer's disease.
Business Development